Search tips
Search criteria 


Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
AAPS PharmSciTech. 2000 September; 1(3): 37–43.
Published online 2000 June 28. doi:  10.1208/pt010320
PMCID: PMC2750348

Evaluation of quick disintegrating calcium carbonate tablets


The purpose of this investigation was to develop a rapidly disintegrating calcium carbonate (CC) tablet by direct compression and compare it with commercially available calcium tablets. CC tablets were formulated on a Carver press using 3 different forms of CC direct compressed granules (Cal-Carb 4450®, Cal-Carb 4457®, and Cal-Carb 4462®). The breaking strength was measured using a Stokes-Monsanto hardness tester. The disintegration and dissolution properties of the tablets were studied using USP methodology. The calcium concentration was determined by an atomic absorption spectrophotometer. Scanning electron microscopy was used to evaluate the surface topography of the granules and tablets. Breaking strength of Cal-Carb 4450®, Cal-Carb 4457®, and Cal-Carb 4462® tablets was in the range of 7.2 to 7.7 kg, as compared with a hardness of 6.2 kg and 10 kg for the commercially available calcium tablets Citracal® and Tums®, respectively. The disintegration time for the tablets presented in the order earlier was 4.1, 2.1, 1.9, 2.9, and 9.7 minutes, respectively. The dissolution studies showed that all formulations released 100% of the elemental calcium in simulated gastric fluid in less than 20 minutes. In summary, this study clearly demonstrated that quick disintegrating CC tablets can be formulated without expensive effervescence technology.

Keywords: Calcium Carbonate Tablets, Quick Disintegrating, Effervescence

Full Text

The Full Text of this article is available as a PDF (452K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Speckmann EW. What is the calcium requirement for optimal bone health? A workshop report. In: Taylor TG, Jenkins NK, editors. Proceedings of the XIII International Congress of Nutrition. London: John Libbey & Company Ltd.; 1985. pp. 580–583.
2. Sheikh MS, Santa-Ana CA, Nicar MJ, Schiller LR, Fordtran JS. Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med. 1987;317:532–536. doi: 10.1056/NEJM198708273170903. [PubMed] [Cross Ref]
3. Recker RR, Bammi A, Barger-Lux MJ, Heaney RP. Calcium absorbability from milk products, an imitation milk and calcium carbonate. Am J Clin Nutr. 1988;47:93–95. [PubMed]
4. Greenspan SL. 73-year old woman with osteoporosis. JAMA. 1999;281:1531–1540. doi: 10.1001/jama.281.16.1531. [PubMed] [Cross Ref]
5. Peel N, Eastell R. ABC of rheumatology. Osteoporosis. Br Med J. 1995;310:989–992. [PMC free article] [PubMed]
6. Walker R. General management of end stage renal disease. Br Med J. 1997;315:1429–1432. [PMC free article] [PubMed]
7. Mayo M, Middleton RK. Calcium carbonate in hyperphosphatemia. DICP. 1991;25:945–947. [PubMed]
8. Ekman M, Reizenstein P, Teigen SW, Ronneberg R. Comparative absorption of calcium from carbonate tablets, lactogluconate/carbonate effervescent tablet, and chloride solution. Bone. 1991;12:93–97. doi: 10.1016/8756-3282(91)90006-5. [PubMed] [Cross Ref]
9. Hansen C, Werner E, Erbes HJ, Larrat V, Kaltwasser JP. Intestinal calcium absorption from different calcium preparations: influence of anion and solubility. Osteoporos Int. 1996;6:386–393. doi: 10.1007/BF01623012. [PubMed] [Cross Ref]
10. Whiting SJ, Pluhator MM. Comparison of in vitro and in vivo tests for determination of availability of calcium from calcium carbonate tablets. J Am Coll Nutr. 1992;11:553–560. [PubMed]
11. Mason NA, Patel JD, Dressman JB, Shimp LA. Consumer vinegar test for determining calcium disintegration. Am J Hosp Pharm. 1992;49:2218–2222. [PubMed]
12. Schirmer RE, Kleber JW, Black HR. Correlation of dissolution, disintegration, and bioavailability of aminosalicylic acid tablets. J Pharm Sci. 1973;62:1270–1274. doi: 10.1002/jps.2600620807. [PubMed] [Cross Ref]
13. Bhagavan HN, Wolkoff BI. Correlation between the disintegration time and the bioavailability of vitamin C tablets. Pharm Res. 1993;10:239–242. doi: 10.1023/A:1018938911420. [PubMed] [Cross Ref]
14. Garf E, Ghanem AH, Mahmoud H, Abdel-Alim H. Studies on the direct compression of pharmaceuticals. Part 19, Effect of moisture on tablet physical parameters and bioavailability. Pharm Ind. 1986;48:292–295.
15. Chowhan ZT. The effect of low- and high-humidity aging on the hardness, disintegration time and dissolution rate of dibasic calcium phosphate-based tablets. J Pharm Pharmacol. 1980;32:10–14. [PubMed]
16. Garr JS, Bangudu AB. Evaluation of sorghum starch as a tablet excipient. Drug Dev Ind Pharm. 1991;17:1–6. doi: 10.3109/03639049109043805. [Cross Ref]
17. Nasipuri RN. Evaluation of cocoyam starch as tablet binder and disintegrant. Pharm Acta Helv. 1979;54:48–53. [PubMed]
18. Gazikalovic E, Obrenovic D, Nidzovic Z, Toskic-Radojicic M. Use of domestically produced corn starch in the manufacture of calcium carbonate tablets. Vojnosanit Pregl. 1988;55:407–10. [PubMed]
19. Makino T, Yamanka M, Kitamori N. Behavior of pregelatinized starch during granulation and its influence on tablet properties. Chem Pharm Bull. 1995;43:2264–2266.
20. Mollan MJ, Celik M. Characterization of directly compressible maltodextrins manufactured by three different processes. Drug Dev Ind Pharm. 1993;19:2335–2358. doi: 10.3109/03639049309047194. [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists